| Serial Number | 97703857 |
| Word Mark | MYQUISTA |
| Filing Date | Monday, December 5, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Wednesday, December 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 18, 2024 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 8, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Thursday, December 8, 2022 | NEW APPLICATION ENTERED |
| Thursday, December 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 12, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, September 13, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 13, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 13, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 25, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 26, 2023 | SUSPENSION LETTER WRITTEN |
| Thursday, October 26, 2023 | LETTER OF SUSPENSION E-MAILED |
| Thursday, October 26, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, April 26, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, May 16, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 29, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 18, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 18, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, December 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 18, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, December 18, 2024 | SOU EXTENSION 1 FILED |